Cerulean Pharma’s nanopharmaceuticals: From bench to bedside

Scott Eliasof

Scott Eliasof

Vice President of Research

Cerulean Pharma Inc.

Scott is vice president of research at Cerulean Pharma Inc. Previously, he was the director of the Chemical Biology Platform at the Broad Institute, directing a multi-disciplinary team of professional scientists and technicians in the fields of synthetic chemistry, analytical chemistry, high-throughput screening, computational science, and software engineering. This interdisciplinary organization is closely affiliated with the laboratory of Stuart Schreiber from Harvard University and is one of the largest and oldest academic screening centers in the country. Prior to joining the Broad Institute, Scott worked at Millennium Pharmaceuticals, where he managed scientific teams in cell biology, molecular biology, neuroscience, and bioinformatics for a large-scale genomics-based drug discovery program. Earlier in his career, Scott was at Neurocrine Biosciences, where he played a key role in the exploration of glutamate transporters in the field of stroke and neurological disorders.

Sponsor & Exhibitor Opportunities

Nanotech Conference & Expo  

Microtech Conference & Expo  

Cleantech Conference & Expo  

*Sponsorship Opportunities: Contact Chris Erb

Platinum Sponsor

BASF


Nanotech Platinum Sponsor

Chinano

Association Sponsor

Clean Technology and Sustainable Industries Organization (CTSI)

Producing Sponsors

Nano Science and Technology Institute

TechConnect

TechConnect Acceleration Partners:

BASF
BayerMaterialScience
Battelle
Bosch
bp
Capewell
DOW
GE
Honda
Hyundai
Ingersoll Rand
intel
Lockheed Martin
MWV
Merck
Momentive
National Grid
novaris
Panasonic
PPG
Roche
Sanofi
Shell
siemens
SK Innovation
solvay
Toyota
*Sponsorship Opportunities: Contact Chris Erb

Free Subscription

E-mail:

pbh(); ?>